Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Lung Cancer

  Free Subscription


12.08.2019

1 AJR Am J Roentgenol
2 Ann Surg Oncol
4 Anticancer Res
1 BMC Cancer
1 Br J Cancer
2 Cancer
1 Clin Cancer Res
2 Clin Lung Cancer
1 Genes Chromosomes Cancer
3 Int J Cancer
2 Int J Radiat Oncol Biol Phys
2 J Cancer Res Clin Oncol
1 J Thorac Oncol
1 JAMA Oncol
2 Lung Cancer
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. TU W, Verma R, Krishna S, McInnes MDF, et al
    Can Adrenal Adenomas Be Differentiated From Adrenal Metastases at Single-Phase Contrast-Enhanced CT?
    AJR Am J Roentgenol. 2018 Sep 12:1-7. doi: 10.2214/AJR.17.19276.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. AKAMINE T, Tagawa T, Ijichi K, Toyokawa G, et al
    The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation.
    Ann Surg Oncol. 2019;26:1544-1551.
    PubMed     Text format     Abstract available

  3. BEANE JD, Wilson GC, Sutton JM, Shuai Y, et al
    Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.
    Ann Surg Oncol. 2019;26:1429-1436.
    PubMed     Text format     Abstract available


    Anticancer Res

  4. MORISAKI T, Kubo M, Umebayashi M, Yuan Y, et al
    Usefulness of the nCounter Analysis System to Monitor Immune-related Biomarkers in PBMCs During Anti-PD-1 Therapy.
    Anticancer Res. 2019;39:4517-4523.
    PubMed     Text format     Abstract available

  5. CORTINOVIS D, Chiari R, Catino A, Grossi F, et al
    Italian Cohort of the Nivolumab EAP in Squamous NSCLC: Efficacy and Safety in Patients With CNS Metastases.
    Anticancer Res. 2019;39:4265-4271.
    PubMed     Text format     Abstract available

  6. UDA NR, Stenner F, Seibert V, Herzig P, et al
    Humanized Monoclonal Antibody Blocking Carbonic Anhydrase 12 Enzymatic Activity Leads to Reduced Tumor Growth In Vitro.
    Anticancer Res. 2019;39:4117-4128.
    PubMed     Text format     Abstract available

  7. YOON SN, Park JH, Lwin TM, Miyake K, et al
    Tumor-sealing Surgical Orthotopic Implantation of Human Colon Cancer in Nude Mice Induces Clinically-relevant Metastases Without Early Peritoneal Carcinomatosis.
    Anticancer Res. 2019;39:4065-4071.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. GUO L, Chen Z, Xu C, Zhang X, et al
    Intratumoral heterogeneity of EGFR-activating mutations in advanced NSCLC patients at the single-cell level.
    BMC Cancer. 2019;19:369.
    PubMed     Text format     Abstract available


    Br J Cancer

  9. YONEDA K, Kuwata T, Kanayama M, Mori M, et al
    Alteration in tumoural PD-L1 expression and stromal CD8-positive tumour-infiltrating lymphocytes after concurrent chemo-radiotherapy for non-small cell lung cancer.
    Br J Cancer. 2019 Aug 7. pii: 10.1038/s41416-019-0541.
    PubMed     Text format     Abstract available


    Cancer

  10. FISET PO, Labbe C, Young K, Craddock KJ, et al
    Anaplastic lymphoma kinase 5A4 immunohistochemistry as a diagnostic assay in lung cancer: A Canadian reference testing center's results in population-based reflex testing.
    Cancer. 2019 Aug 7. doi: 10.1002/cncr.32422.
    PubMed     Text format     Abstract available

  11. KHOZIN S, Miksad RA, Adami J, Boyd M, et al
    Real-world progression, treatment, and survival outcomes during rapid adoption of immunotherapy for advanced non-small cell lung cancer.
    Cancer. 2019 Aug 5. doi: 10.1002/cncr.32383.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  12. ISHIZAWA K, Yamanaka M, Saiki Y, Miyauchi E, et al
    CD45+CD326+ Cells are predictive of poor prognosis in Non-Small Cell Lung Cancer patients.
    Clin Cancer Res. 2019 Aug 5. pii: 1078-0432.CCR-19-0545.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  13. GUDENKAUF LM, Clark MM, Novotny PJ, Piderman KM, et al
    Spirituality and Emotional Distress Among Lung Cancer Survivors.
    Clin Lung Cancer. 2019 Jun 19. pii: S1525-7304(19)30157.
    PubMed     Text format     Abstract available

  14. WEN J
    Comment on the data of the article titled "Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients".
    Clin Lung Cancer. 2019 Jun 26. pii: S1525-7304(19)30174.
    PubMed     Text format    


    Genes Chromosomes Cancer

  15. YAO S, Dong SS, Ding JM, Rong Y, et al
    Sex-Specific SNP-SNP Interaction Analyses within Topologically Associated Domains Reveals ANGPT1 as A Novel Tumor Suppressor Gene for Lung Cancer.
    Genes Chromosomes Cancer. 2019 Aug 5. doi: 10.1002/gcc.22793.
    PubMed     Text format     Abstract available


    Int J Cancer

  16. JIANG T, Chu Q, Wang H, Zhou F, et al
    EGFR-TKIs plus local therapy demonstrated survival benefit than EGFR-TKIs alone in EGFR-mutant NSCLC patients with oligometastatic or oligoprogressive liver metastases.
    Int J Cancer. 2019;144:2605-2612.
    PubMed     Text format     Abstract available

  17. ENDRIS V, Buchhalter I, Allgauer M, Rempel E, et al
    Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels.
    Int J Cancer. 2019;144:2303-2312.
    PubMed     Text format     Abstract available

  18. POTJER TP, Bollen S, Grimbergen AJEM, van Doorn R, et al
    Multi-gene panel sequencing of established and candidate melanoma susceptibility genes in a large cohort of Dutch non-CDKN2A/CDK4 melanoma families.
    Int J Cancer. 2018 Nov 10. doi: 10.1002/ijc.31984.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  19. JIN P, Machiels M, Crama KF, Visser J, et al
    Dosimetric benefits of mid-position compared with internal target volume strategy for esophageal cancer radiation therapy.
    Int J Radiat Oncol Biol Phys. 2018 Sep 22. pii: S0360-3016(18)33804.
    PubMed     Text format     Abstract available

  20. TUCKER SL, Xu T, Paganetti H, Deist T, et al
    Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2019;103:403-410.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  21. HAN H, Zhao Y, Gao Z, Zheng D, et al
    A prognostic score system with lymph node ratio in stage IIIA-N2 NSCLC patients after surgery and adjuvant chemotherapy.
    J Cancer Res Clin Oncol. 2019;145:2115-2122.
    PubMed     Text format     Abstract available

  22. HORN LC, Hohn AK, Stark S, Einenkel J, et al
    Endocervical adenocarcinoma in situ (AIS) with ovarian and pulmonary involvement: report of a case and review of the literature suggesting a "seed and soil hypothesis".
    J Cancer Res Clin Oncol. 2019;145:2061-2069.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  23. GOWING SD, Chow SC, Cools-Lartigue JJ, Chen CB, et al
    Gram-Negative Pneumonia Augments Non-Small Cell Lung Cancer Metastasis Through Host Toll-like Receptor 4 Activation.
    J Thorac Oncol. 2019 Aug 2. pii: S1556-0864(19)30653.
    PubMed     Text format     Abstract available


    JAMA Oncol

  24. STINCHCOMBE TE, Janne PA, Wang X, Bertino EM, et al
    Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
    JAMA Oncol. 2019 Aug 8. pii: 2747878. doi: 10.1001/jamaoncol.2019.1847.
    PubMed     Text format     Abstract available


    Lung Cancer

  25. BARBONE F, Barbiero F, Fasola G
    Correspondence regarding "Low-dose computed tomography screening for lung cancer in people with workplace exposure to asbestos".
    Lung Cancer. 2019 Jul 27. pii: S0169-5002(19)30564.
    PubMed     Text format    

  26. GRONDAHL V, Binderup T, Langer SW, Petersen RH, et al
    Erratum to "Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence" [Lung Cancer 132 (June) (2019) 141-149].
    Lung Cancer. 2019 Jul 31. pii: S0169-5002(19)30561.
    PubMed     Text format    


    PLoS One

  27. PIPER AJ, Clark JL, Mercado-Matos J, Matthew-Onabanjo AN, et al
    Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).
    PLoS One. 2019;14:e0220567.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: